BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26043384)

  • 1. Warm autoimmune hemolytic anemia.
    Naik R
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
    Loriamini M; Cserti-Gazdewich C; Branch DR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
    de Boer ECW; Jalink M; Delvasto-Nuñez L; Meulenbroek EM; Baas I; Janssen SR; Folman CC; Gelderman KA; Wouters D; Engel MD; de Haas M; Kersten MJ; Jongerius I; Zeerleder S; Vos JMI
    Blood Adv; 2023 Jul; 7(13):3128-3139. PubMed ID: 36920779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement in hemolytic anemia.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation-etiological and therapeutic issues.
    Turudic D; Dejanovic Bekic S; Mucavac L; Pavlovic M; Milosevic D; Bilic E
    Front Pediatr; 2023; 11():1217536. PubMed ID: 37794962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.
    Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG
    Front Immunol; 2021; 12():791429. PubMed ID: 34899761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps.
    Mulder FVM; Evers D; de Haas M; Cruijsen MJ; Bernelot Moens SJ; Barcellini W; Fattizzo B; Vos JMI
    Front Immunol; 2023; 14():1228142. PubMed ID: 37795092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.
    Berentsen S
    Front Immunol; 2020; 11():590. PubMed ID: 32318071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrophagocytosis in autoimmune immunoglobulin A-mediated hemolysis.
    Gollamudi J; Dasgupta SK; Thiagarajan P
    Transfusion; 2023 Oct; 63(10):1978-1982. PubMed ID: 37668082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report.
    Hanna M; Carcao M
    J Med Case Rep; 2023 Oct; 17(1):418. PubMed ID: 37794483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: complement receptor 1 therapeutics for prevention of immune hemolysis.
    Yazdanbakhsh K
    Immunohematology; 2005; 21(3):109-18. PubMed ID: 16178668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
    Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
    Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of complement-mediated immune hemolysis by a small molecule compound.
    Mqadmi A; Zheng X; Song J; Abramowitz S; Giclas P; Yazdanbakhsh K
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1465-71. PubMed ID: 15555593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warm autoantibodies mimicking alloantibodies: Three cases of autoantibodies with unusual antigenic specificity.
    Jacobs JW; Binns TC; Abels E; Silva Campos JJ; Elkabbani R; Kress A; Sostin N; Tormey CA
    Am J Clin Pathol; 2023 Dec; 160(6):561-565. PubMed ID: 37598315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of laboratory characteristics, analysis of alloimmunization, and searching for predictors related to survival in patients with Autoimmune Hemolytic Anemia.
    Durigon G; Sekine L; Franz JPM; Fogliatto LM; da Rocha Silla LM
    Transfus Apher Sci; 2023 Oct; 62(5):103741. PubMed ID: 37271665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warm autoimmune hemolytic anemia: new insights and hypotheses.
    Branch DR
    Curr Opin Hematol; 2023 Nov; 30(6):203-209. PubMed ID: 37497853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the complement system for prevention of red cell destruction.
    Yazdanbakhsh K
    Curr Opin Hematol; 2005 Mar; 12(2):117-22. PubMed ID: 15725901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement in alloimmunization and hyperhemolysis.
    Chonat S; Mener A; Verkerke H; Stowell SR
    Curr Opin Hematol; 2020 Nov; 27(6):406-414. PubMed ID: 32889827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody based therapeutics for autoimmune hemolytic anemia.
    Cavallaro F; Barcellini W; Fattizzo B
    Expert Opin Biol Ther; 2023; 23(12):1227-1237. PubMed ID: 37874225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of adsorption techniques in serological evaluation of warm autoimmune haemolytic anaemia.
    Das SS; Chaudhary R
    Blood Transfus; 2009 Oct; 7(4):300-4. PubMed ID: 20011641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.